Skip to Main Content

Author Details

Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
1981
400
103
PMIDPaper TitleJournal TitlePublished Year
36730407The NIH-led research response to COVID-19.Science2023
37555786Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy.AIDS2023
37349033Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study.Lancet Glob Health2023
37213438Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.NEJM Evid2023
37179012Clinical evaluation of commercial SARS-CoV-2 serological assays in a malaria endemic setting.J Immunol Methods2023
37275364Epidemiologic, clinical, and serum markers may improve discrimination between bacterial and viral etiologies of childhood pneumonia.Front Med (Lausanne)2023
36963916On the importance and challenges of global access to proven life-saving treatments for Ebolavirus.Lancet Infect Dis2023
36448028Dynamics of SARS-CoV-2 variants characterized during different COVID-19 waves in Mali.IJID Reg2023
36580481Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV.J Infect Dis2023
36796971Clinical research as a critical component of epidemic response: the case of PREVAIL in Liberia.Lancet Glob Health2023
34928698Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.Ann Intern Med2022
35679250Correction: An observational prospective cohort study of the epidemiology of hospitalized patients with acute febrile illness in Indonesia.PLoS Negl Trop Dis2022
35442221Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.AIDS2022
35580040Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.Am J Respir Crit Care Med2022
35605238A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings.Ann Intern Med2022
35532087QuasiSeq: profiling viral quasispecies via self-tuning spectral clustering with PacBio long sequencing reads.Bioinformatics2022
36516078Randomized Trial of Vaccines for Zaire Ebola Virus Disease.N Engl J Med2022
36001716Monkeypox - Past as Prologue.N Engl J Med2022
35939810Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.Ann Intern Med2022
35969864The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma.Ann Intern Med2022
35938597Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D<sup>2</sup>EFT.HIV Res Clin Pract2022
35935779Mild reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant: First case report from Indonesia.Front Med (Lausanne)2022
36037469The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.Ann Intern Med2022
35963234Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO).Med2022
36028577Quantitative PET imaging of the CD4 pool in nonhuman primates.Eur J Nucl Med Mol Imaging2022
35325185DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update).Nucleic Acids Res2022
35265726Association of Lower Exposure Risk With Paucisymptomatic/Asymptomatic Infection, Less Severe Disease, and Unrecognized Ebola Virus Disease: A Seroepidemiological Study.Open Forum Infect Dis2022
35298440RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19.JCI Insight2022
32678528Research in the Context of a Pandemic.N Engl J Med2021
33709142PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.Clin Infect Dis2021
34556365Tackling the burden of mumps in the military: A report of the Defense Health Board.Vaccine2021
34470655Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.Trials2021
34460416Prevalence of HIV Infection and Resistance Mutations in Patients Hospitalized for Febrile Illness in Indonesia.Am J Trop Med Hyg2021
34506540The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa.PLoS One2021
34050748NIAID ClinRegs-a Public Database of Country Clinical Research Regulatory and Ethics Requirements: Design and Utilization Analysis.Clin Infect Dis2021
33974707Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope Specificity.J Infect Dis2021
33460347SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.Ann Intern Med2021
33399856Characterization of Ebola Virus-Associated Eye Disease.JAMA Netw Open2021
33356051A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.N Engl J Med2021
33232588A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.N Engl J Med2021
31562760Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques.J Infect Dis2020
32029589Defective HIV-1 proviruses produce viral proteins.Proc Natl Acad Sci U S A2020
31923174An observational prospective cohort study of the epidemiology of hospitalized patients with acute febrile illness in Indonesia.PLoS Negl Trop Dis2020
33354527Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia.Afr J Lab Med2020
32609976Four Decades of HIV/AIDS - Much Accomplished, Much to Do.N Engl J Med2020
32702095Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.J Infect Dis2020
32445440Remdesivir for the Treatment of Covid-19 - Final Report.N Engl J Med2020
32109011Covid-19 - Navigating the Uncharted.N Engl J Med2020
32395747No Bioterror Battle Plan Survives First Outbreak.Mil Med2020
31298273Eight-day Inpatient Directly Observed Therapy for Antiretroviral Therapy (ART) Failure: A Tool For Preventing Unnecessary ART Changes and Optimizing Adherence Support.Clin Infect Dis2020
  • 1 - 50 of 400

Recommended Authors

Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 1
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 4
University of California san francisco
Career Start Year 2002
Number of shared co-authors 8
Vitalant Research Institute
Career Start Year 2001
Number of shared co-authors 7
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 5
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 7
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 1988
Number of shared co-authors 6
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 5
University of Massachusetts Medical School-Baystate
Career Start Year 1988
Number of shared co-authors 3
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 12
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 7
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 3
MK University of Rochester
Career Start Year 1986
Number of shared co-authors 3
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
University of Washington
Career Start Year 1984
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 1
Perelman School of Medicine, the University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 1
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 11
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 11
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 11
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 10
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 7
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 10
Institute for Global Health Sciences, University of California san francisco
Career Start Year 1977
Number of shared co-authors 3
University of California San Diego
Career Start Year 1975
Number of shared co-authors 0
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 25
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 11
Wistar Institute
Career Start Year 1958
Number of shared co-authors 6

Collaborators

National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 68
VA Medical Center
Co-authored papers 8
Massachusetts General Hospital, Harvard School of Medicine,
Co-authored papers 7
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 7
Hospital Germans Trias i Pujol
Co-authored papers 7
Frederick National Laboratory for Cancer Research, Inc.
Co-authored papers 7
Boston University
Co-authored papers 6
National Eye Institute
Co-authored papers 5
US Centers for Disease Control and Prevention
Co-authored papers 5
Intermountain Medical Center and the University of Utah
Co-authored papers 5
University of Colorado School of Medicine
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 4
Wake Forest University
Co-authored papers 4
Co-authored papers 4
The Fenway Institute
Co-authored papers 4
Faculty of Medicine and Odonto-Stomatology (FMOS)/University of Sciences
Co-authored papers 4
Co-authored papers 4
Clinical Center, National Institutes of Health
Co-authored papers 4
Emory University School of Medicine
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 3
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 3
National Institute of Biomedical Research (INRB)
Co-authored papers 3
Co-authored papers 3
&quotMagna Graecia&quot University
Co-authored papers 3
Co-authored papers 3
Cardiovascular Research Institute, University of California san francisco
Co-authored papers 3
Frederick National Laboratory
Co-authored papers 3
University Clinical Research Center, University of Sciences
Co-authored papers 3
Infectious Disease Clinical Research Program, Uniformed Services University
Co-authored papers 3
University of Colorado School of Medicine
Co-authored papers 3